LFCR Q4 2020 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$156M+2.2% YoY

Gross Profit

$24M15.4% margin

Operating Income

-$13M-8.4% margin

Net Income

-$15M-9.7% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$17M

Stock-Based Comp.

$538,000

Balance Sheet

Total Assets

$541M

Total Liabilities

$310M

Stockholders' Equity

$231M

Cash & Equivalents

$360,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$156M	$153M	+2.2%
Gross Profit	$24M	$26M	-8.1%
Operating Income	-$13M	$2M	-628.6%
Net Income	-$15M	-$262,000	-5682.1%